Skip to main content

Table 1 Socio-demographic characteristics and medical data of patients

From: Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment

  Total (n = 140) CAM users (n = 97) CAM non-users (n = 43) p-valuec
Age, years, mean (SD) 12.3 (5.4) 12.0 (4.8) 12.8 (6.5) 0.51d
Age categories, years 0.05
  < 2 1 (0.7) 0 (0) 1 (2.3)  
 2–4 8 (5.7) 3 (3.1) 5 (11.6)  
 5–7 21 (15.0) 15 (15.5) 6 (14.0)  
 8–12 55 (39.3) 43 (44.3) 12 (27.9)  
 13–18 36 (25.7) 26 (26.8) 10 (23.3)  
  > 18 19 (13.6) 10 (10.3) 9 (20.9)  
 Age at diagnosis,a years, mean (SD) 7.1 (5.0) 7.0 (4.6) 7.5 (5.7) 0.59d
Child’s genderb 0.46
 Female 69 (49.3) 50 (51.6) 19 (44.2)  
 Male 71 (50.7) 47 (48.5) 24 (55.8)  
Time intervals since diagnosis at time of study 0.03
 During OT 15 (10.7) 10 (10.3) 5 (11.6)  
 1st year after the end of OT 19 (13.6) 9 (9.3) 10 (23.3)  
 Between 1 and 5 years after the end of OT 52 (37.1) 43 (44.3) 9 (20.9)  
  ≥ 5 years after the end of OT 50 (35.7) 33 (34.0) 17 (39.5)  
 Other (recurrence or 2nd cancer) 4 (2.9) 2 (2.1) 2 (4.7)  
Type of cancer 0.51
 Leukemia 42 (30.0) 30 (30.9) 12 (27.9)  
 Malignant solid tumors 42 (30.0) 29 (30.0) 13 (30.2)  
 Leukemia/malignant solid tumors 3 (2.1) 3 (3.1) 0 (0.0)  
 Central nervous system (including retinoblastoma) 34 (24.3) 25 (25.8) 9 (20.9)  
 Lymphoma 13 (9.3) 7 (7.2) 6 (14.0)  
 Other 6 (4.3) 3 (3.1) 3 (7.0)  
Treatment received (4 different binary variables)
 Chemotherapy 106 (76.3) 73 (76.0) 33 (76.7) 0.64
 Surgery 82 (58.6) 56 (57.7) 26 (60.5) 0.85
 Radiotherapy 33 (23.6) 22 (22.7) 11 (25.6) 0.83
 Stem cell transplantation 16 (11.4) 14 (14.4) 2 (4.7) 0.15
CAM supplemental healthcare insurance 0.004
 Yes 102 (72.9) 78 (80.4) 24 (55.8)  
 No 28 (20.0) 16 (16.5) 12 (27.9)  
 Don’t know 10 (7.1) 3 (3.1) 7 (16.3)  
  1. All values represent n (%) except where otherwise indicated.
  2. CAM Complementary and alternative medicine, OT Oncology treatment
  3. aMean age (SD) at diagnosis of non-respondents (n = 278): 8.6 (5.5) years
  4. bGender of non-respondents (n = 278): female n = 124 (44.6%), male n = 154 (55.4%)
  5. cStatistical analyses were conducted by using Fisher’s exact test, except where otherwise indicated
  6. dThe student t-test was used for age when considered continuous